List/Grid Tag Archives: CNCF 2010
CNCF 2010 ~ Dr Kate Matthay presents update on NANT trials
New Approaches to Neuroblastoma Therapy (NANT) consortium offers trials for relapsed and refractory neuroblastoma
Dr Kate Matthay spoke at the Children’s Neuroblastoma Cancer Foundation CNCF parent conference in Chicago July 10, 2010, detailing the status of several NANT trials. She mentioned that these trials open and close periodically, so contacting the principal investigator is the best way ...
CNCF 2010 ~ Dr Giselle Sholler updates on NMTRC trials for neuroblastoma
New drug combinations, personalized medicine proof-of-concept demonstrated, parents involved
Dr Giselle Sholler is the chair for the The Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) based at Vermont Children’s Hospital at Fletcher Allen Heath Care, University of Vermont College of Medicine. Dr Sholler presented an update on trials offered by the NMTRC to parents ...
CNCF 2010 ~ Allogeneic (donor) stem cell transplant for neuroblastoma
New donor transplant trial open for relapsed or refractory neuroblastoma
Dr Sandeep Soni spoke at CNCF (Children’s Neuroblastoma Cancer Foundation) Parent Conference in Chicago July 10, 2010. Dr Soni is a member of the Pediatric Blood and Marrow Transplant program at Nationwide Children’s Hospital and an Assistant Professor of Clinical Pediatrics at Ohio State University College of Medicine ...
CNCF 2010 ~ Seneca Valley Virus NTX-010 is first oncolyic virus ever used in US children
Dr Michael Burke from the University of Minnesota is the Principal Investigator of the Seneca Valley Virus trial COG-ADVL0911:
“Seneca Valley Virus-001 in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features”
Dr Burke gave a presentation on this trial at the CNCF parent conference July 10, 2010.
By early July, ...
CNCF 2010 ~ Dr Peter Zage on 3F8 phase II randomized trial
Dr Peter Zage from MD Anderson in Houston TX gave a presentation at the Children’s Neuroblastoma Cancer Foundation (CNCF) conference Saturday July 10, 2010 on the 3F8 randomized trial:
A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients (NCT00969722)
This trial is funded by ...
CNCF 2010 ~ 8th Annual Neuroblastoma Conference for Parents
Recap of presentations
I have so much more to report on ASCO and ANR (coming soon), but should share information about this conference first. This year’s conference was exceptional. The presentations covered a wide range of important topics, and I am convinced the 130 parents in attendance walked away with essential information for their families. This conference is extraordinary in that no rare ...
